ArticleJournal of cosmetic dermatology2025
Low-Energy Delicate Pulsed Light Therapy for Sensitive Skin: A Retrospective Study.
Article in Journal of cosmetic dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06915636 (A Randomized Face-to-face Comparative Study of Low-energy 1064nm Laser With Large Spot Size and DPL in the Treatment of Rosacea), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Randomized Face-to-face Comparative Study of Low-energy 1064nm Laser With Large Spot Size and DPL in the Treatment of Rosacea
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundSensitive skin (SS) is a multifactorial syndrome that affects about half of the world's population. However, there is no standardized treatment protocol. Photovoltaic technology has been widely used in recent years for the treatment of sensitive skin, but the efficacy of low-energy delicate pulsed light (DPL) in the treatment of sensitive skin is unknown.
objectiveTo explore the efficacy and safety of low-energy DPL treatment for sensitive skin.
methodsThis study included 181 patients with SS who attended the Department of Dermatology from January 2019 to January 2022. All patients were treated with DPL (5.0-6.8 J/cm
resultsAmong 181 patients, 86 were SS alone, 32 were rosacea with SS, 32 were acne with SS, and 31 were dermatitis with SS. A significant difference was observed between patients' baseline and final SS-10 scores (p < 0.001). Statistically significant differences were found between the patients' CEA scores at different visits (p < 0.001). Clinical photographs demonstrated significant improvements in facial redness and skin color. VISIA-CR analysis showed a considerable reduction in erythema values at the final treatment visit compared to baseline (p < 0.001). No obvious adverse effects were observed in any of the patients.
conclusionLow-energy DPL is an effective and safe treatment for sensitive skin.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.